European Stroke Organisation (ESO) Guidelines on Covert Small Vessel Disease

Published by ESO on May 20, 2021

Disclaimer

Sponsors

Contact

Abstract

Language

en

PICOS

PICO 1.1

Population
Patients with covert cerebral small vessel diseases
Intervention
Antihypertensive treatment
Comparator
Less intensive or avoiding antihypertensive treatment
Outcomes

PICO 2.1

Population
Patients with covert cerebral small vessel disease
Intervention
Antiplatelet treatment
Comparator
Less intense or avoiding antiplatelet treatment
Outcomes

PICO 3.1

Population
Patients with covert small vessel diseases
Intervention
Lipid lowering treatment
Comparator
Less intense or avoiding lipid lowering treatment
Outcomes

PICO 4.1

Population
Patients with covert cerebral small vessel diseases
Intervention
Physical Exercise
Comparator
No Physical Exercise
Outcomes

PICO 5.1

Population
Patients with covert small vessel diseases who may (or may not) require glucose lowering therapies
Intervention
Drugs which reduce plasma glucose levels
Comparator
No drugs which reduce plasma glucose levels
Outcomes

PICO 6.1

Population
Patients with covert cerebral small vessel diseases
Intervention
Conventional anti-dementia drugs
Comparator
Avoiding conventional anti-dementia drugs
Outcomes